Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
What you’ll do
- Evaluate NGS sequencing results
- Conduct pathology review including IHC for both research and clinical specimens
- Participate in clinical report review and delivery
- Collaborate with multi-disciplinary team focused on answering key biological questions
- Work to establish and maintain CLIA/CAP compliance in a novel field
Qualifications
- MD with a current medical license and board-certified in Anatomic Pathology and/or Clinical Pathology, with board certification or eligibility in Molecular Genetic Pathology
- Clinical experience with next generation sequencing interpretation
- Detailed knowledge and experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred
- Excellent managerial, organizational, reporting and communication skills
- Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR)
- Experience ensuring compliance of a clinical laboratory to regulatory standards
Preferred Qualifications:
- Experience with homegrown systems
- Willingness to work non-traditional schedules
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
#LI-SH1
#LI-Hybrid
#LI-Remote
#LI-Onsite
